SCHEMBL32663577

SCHEMBL32663577

CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@@H]5CCN(CCF)C5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30313852 1.00 BCL2 (1.00) BCL2
SCHEMBL30314110 1.00 BCL2 (1.00) BCL2
SCHEMBL1699847 1.00 BCL2 (1.00) BCL2
SCHEMBL1809096 1.00 BCL2 (1.00) BCL2
SCHEMBL1700842 0.95 BCL2 (1.00) BCL2
SCHEMBL30314090 0.95 BCL2 (1.00) BCL2
SCHEMBL30313913 0.95 BCL2 (1.00) BCL2
SCHEMBL1699948 0.95 BCL2 (1.00) BCL2
SCHEMBL1700837 0.95 BCL2 (1.00) BCL2
SCHEMBL1701872 0.94 BCL2 (0.89) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4682148-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES AbbVie Ireland Unlimited Company (IE) 2026-01-21 — — EP disclosed
Send feedback